Back to Figures
VR

Vivek Ramaswamy

Biotech Entrepreneur
Republican
Conservative
New Right
Business Leader

Vivek Ramaswamy, born in 1985 to Indian immigrant parents, is an American entrepreneur, author, and politician. A Harvard biology graduate and Yale Law alumnus, he worked at Goldman Sachs before founding Roivant Sciences in 2014, a biopharmaceutical firm that spun off successful drug developers. In 2021, he published "Woke, Inc.," critiquing corporate activism, and launched Strive Asset Management in 2022 to prioritize shareholder value over ESG. He ran for the 2024 Republican presidential nomination, withdrew after Iowa, and endorsed Donald Trump. President-elect Trump appointed him co-chair of the Department of Government Efficiency with Elon Musk.

Share:
88
/ 100
Independent
Independence Score

Says vs Does

What they claim vs what their actions show

🗣️ SAYS THEY ARE
America First conservative and anti-woke populist
⚡ ACTUALLY ALIGNS
Biotech and pharmaceutical industry interests

🎯 Primary Loyalties (Ranked)

  1. Biotech and pharmaceutical sector
  2. Free-market deregulation
  3. Anti-DEI conservatism
  4. High-skilled immigration policy

đź“‹ Actions That Prove It

  • âś“Founded Roivant Sciences in 2014, a biopharmaceutical company that raised over $7 billion and partnered with Pfizer on a $7.2 billion deal for a COVID-19 treatment.
  • âś“Proposed abolishing the FDA during his 2024 Republican presidential campaign to expedite drug approvals and reduce regulatory barriers.
  • âś“Defended the H-1B visa program in December 2024 social media posts and interviews, stating the U.S. needs top global engineering talent from countries like India.
  • âś“Published 'Woke, Inc.' in 2021, critiquing corporate adoption of ESG and DEI initiatives while advocating for reduced government intervention in business.

⚠️ Contradictions

  • •Criticized Big Pharma's regulatory capture and influence but Roivant Sciences benefited from FDA approvals and partnerships with major firms like Pfizer.
  • •Portrayed as populist prioritizing American workers but supported H-1B visas, which enable U.S. firms to hire foreign professionals at potentially lower costs.
  • •Anti-establishment rhetoric against elites contrasts with personal career in hedge funds (e.g., at Stratus) and biotech SPAC mergers generating significant personal wealth.

Career Background

  • •Founder and CEO of Roivant Sciences (2014-2021)
  • •Executive Chairman of Roivant Sciences (2021-2023)
  • •Founder and CEO of Strive Asset Management (2022-present)
  • •Republican candidate for President of the United States (2023-2024)
  • •Co-chair of the Department of Government Efficiency (DOGE, announced November 2024)

Endorsements

  • •Endorsed Donald Trump for President after withdrawing from 2024 GOP primary (January 2024)
  • •Received endorsement from Florida Governor Ron DeSantis (early 2024 campaign support noted)
  • •Received praise and alliance from Donald Trump post-primary

Affiliations & Memberships

Republican Party
Biotech industry (Roivant Sciences)
Anti-ESG investing (Strive Asset Management)
Ally to Donald Trump and Elon Musk (DOGE initiative)